Valuation DHG Pharmaceutical

Stocks

DHG

VN000000DHG0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. 30/10/2026			5-day change	1st Jan Change
86,900.00 ^VND	-0.46%		-1.14%	-15.05%

10-20	DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
08-21	DHG Pharma Announces Final Dividend for 2025, Payable on 30 Sep. 2026	CI

Company Valuation: DHG Pharmaceutical

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	14,774,306	11,100,341	13,597,591	13,584,517	13,375,323	11,361,834	-	-
Change	-	-24.87%	22.5%	-0.1%	-1.54%	-15.05%	-	-
Enterprise Value (EV) ¹	12,828,324	11,100,341	11,845,622	11,426,573	11,221,427	9,499,334	9,504,034	9,511,034
Change	-	-13.47%	6.71%	-3.54%	-1.8%	-15.35%	0.05%	0.07%
P/E	19.8x	11.6x	13.4x	18x	15.4x	12.2x	11.6x	10.8x
PBR	3.9x	2.59x	-	-	-	-	-	-
PEG	-	0.4x	2.1x	-0.7x	1x	1.78x	1.96x	1.64x
Capitalization / Revenue	3.69x	2.37x	2.71x	2.78x	2.54x	2.09x	2x	1.91x
EV / Revenue	3.2x	2.37x	2.36x	2.34x	2.13x	1.75x	1.67x	1.6x
EV / EBITDA	13.6x	9.59x	10.4x	10.5x	10.2x	8.22x	7.61x	7.12x
EV / EBIT	14.5x	9.98x	11.2x	12.4x	11.4x	9.07x	8.36x	7.8x
EV / FCF	30x	16.6x	-48.1x	9.3x	9.48x	19.5x	11.7x	11.2x
FCF Yield	3.34%	6.01%	-2.08%	10.8%	10.5%	5.14%	8.56%	8.9%
Dividend per Share ²	4,000	-	-	10,000	10,000	7,000	7,200	7,500
Rate of return	3.54%	-	-	9.62%	9.78%	8.06%	8.29%	8.63%
EPS ²	5,720	7,318	7,786	5,763	6,644	7,100	7,521	8,016
Distribution rate	69.9%	-	-	174%	151%	98.6%	95.7%	93.6%
Net sales ¹	4,003,170	4,676,016	5,015,395	4,884,868	5,266,963	5,435,000	5,690,600	5,958,700
EBITDA ¹	944,647	1,157,079	1,140,985	1,089,971	1,105,507	1,155,200	1,248,900	1,335,900
EBIT ¹	884,537	1,112,058	1,053,025	920,276	986,499	1,047,900	1,137,100	1,219,600
Net income ¹	777,220	988,455	1,051,490	778,920	897,576	928,400	983,400	1,048,100
Net Debt ¹	-1,945,982	-	-1,751,969	-2,157,944	-2,153,896	-1,862,500	-1,857,800	-1,850,800
Reference price ²	113,000.00	84,900.00	104,000.00	103,900.00	102,300.00	86,900.00	86,900.00	86,900.00
Nbr of stocks (in thousands)	130,746	130,746	130,746	130,746	130,746	130,746	-	-
Announcement Date	20/01/22	19/01/23	19/01/24	20/01/25	20/01/26	-	-	-

¹VND in Million²VND

Estimates

P/E, Detailed evolution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DHG PHARMACEUTICAL	12.24x	1.75x	8.22x	8.06%	440M
ELI LILLY AND COMPANY	41.42x	14.04x	31.11x	0.48%	1,263B
JOHNSON & JOHNSON	39.99x	6.71x	18.89x	1.95%	658B
ABBVIE INC.	36.71x	8.6x	17.71x	2.33%	521B
ROCHE HOLDING AG	21.74x	5.27x	13.12x	2.48%	391B
MERCK & CO., INC.	106.24x	6.06x	25.8x	2.28%	369B
NOVARTIS AG	23.19x	5.95x	14.36x	2.69%	307B
ASTRAZENECA PLC	24.47x	4.89x	13.59x	1.77%	290B
AMGEN INC.	29.55x	7.53x	13.48x	2.16%	252B
GILEAD SCIENCES, INC.	-41.18x	7.46x	46.76x	1.93%	212B
Average	29.44x	6.83x	20.30x	2.61%	426.24B
Weighted average by Cap.	37.15x	8.83x	22.81x	1.69%